LEADER 01302nam--2200373---450- 001 990003558190203316 005 20110830125056.0 035 $a000355819 035 $aUSA01000355819 035 $a(ALEPH)000355819USA01 035 $a000355819 100 $a20110830d1979----km-y0itay50------ba 101 0 $aita 102 $aIT 105 $aa---||||001yy 200 1 $a<> romanzi cavallereschi miniati a Napoli$fAlessandra Perriccioli Saggese$gcon una nota paleografica di Catello Salvati e una nota filologica di Vittorio Marmo 210 $a[S.l.]$cBanca Sannitica$dstampa 1979 215 $a236 p., [59] c. di tav.$cill.$d30 cm 225 2 $aMiniatura e arti minori in Campania$v14 410 0$12001$aMiniatura e arti minori in Campania$v14 606 0 $aManoscritti miniati$yNapoli$zSec. 13.-15.$2BNCF 606 0 $aRomanzi cavallereschi$xManoscritti miniati 676 $a096 700 1$aPERRICCIOLI SAGGESE,$bAlessandra$038872 702 1$aSALVATI,$bCatello 702 1$aMARMO,$bVittorio 801 0$aIT$bsalbc$gISBD 912 $a990003558190203316 951 $aXII.2.A. 757$b233204 L.M.$cXII.2.A.$d00298655 959 $aBK 969 $aUMA 979 $aIANNONE$b90$c20110830$lUSA01$h1250 996 $aRomanzi cavallereschi miniati a Napoli$9609416 997 $aUNISA LEADER 02220nam 2200541 450 001 9910787427103321 005 20230124192958.0 010 $a0-231-53821-9 024 7 $a10.7312/brow13328 035 $a(CKB)3710000000346484 035 $a(EBL)1912258 035 $a(OCoLC)902419277 035 $a(MiAaPQ)EBC1912258 035 $a(DE-B1597)458260 035 $a(OCoLC)984687323 035 $a(DE-B1597)9780231538213 035 $a(Au-PeEL)EBL1912258 035 $a(CaPaEBR)ebr11012220 035 $a(CaONFJC)MIL690462 035 $a(EXLCZ)993710000000346484 100 $a20150202h20152015 uy 0 101 0 $aeng 135 $aurun#---|u||u 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 10$aFaces of power $econstancy and change in United States foreign policy from Truman to Obama /$fSeyom Brown 205 $aThird edition. 210 1$aWest Sussex, England :$cColumbia University Press,$d2015. 210 4$d©2015 215 $a1 online resource (861 p.) 300 $aIncludes index. 311 0 $a0-231-13329-4 327 $tFront matter --$tCONTENTS --$tPreface --$tIntroduction: Constancy and Change Since WWII --$tPART I. THE TRUMAN ADMINISTRATION --$tPART II. THE EISENHOWER ERA --$tPART III. THE KENNEDY-JOHNSON YEARS --$tPART IV. STATECRAFT UNDER NIXON AND FORD --$tPART V. THE CARTER PERIOD --$tPART VI. THE REAGAN ERA-REALISM OR ROMANTICISM? --$tPART VII. PRUDENTIAL STATECRAFT WITH GEORGE HERBERT WALKER BUSH --$tPART VIII. CLINTON'S GLOBALISM --$tPART IX. THE FREEDOM AGENDA OF GEORGE W. BUSH --$tPART X. OBAMA'S UNIVERSALISM VERSUS A STILL-FRAGMENTED WORLD --$tEpilogue --$tNotes --$tIndex 330 $a
606 $aPOLITICAL SCIENCE / American Government / Executive Branch$2bisacsh 607 $aUnited States$xForeign relations$y1945-1989 607 $aUnited States$xForeign relations$y1989- 615 7$aPOLITICAL SCIENCE / American Government / Executive Branch. 676 $a327.73 700 $aBrown$b Seyom$0545304 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910787427103321 996 $aFaces of power$91471829 997 $aUNINA LEADER 06746nam 2200661 450 001 9910809425103321 005 20220429134720.0 010 $a1-119-14109-5 010 $a1-119-14108-7 010 $a1-119-31624-3 035 $a(CKB)4330000000010209 035 $a(EBL)4622918 035 $a(Au-PeEL)EBL4622918 035 $a(CaPaEBR)ebr11244265 035 $a(CaONFJC)MIL945143 035 $a(CaSebORM)9781119141075 035 $a(MiAaPQ)EBC4622918 035 $a(OCoLC)954732931 035 $a(EXLCZ)994330000000010209 100 $a20160901h20162016 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 10$aAnalytics for insurance $ethe real business of big data /$fTony Boobier 210 1$aChichester, England :$cWiley,$d2016. 210 4$d©2016 215 $a1 online resource (299 p.) 225 1 $aWiley Finance Series 300 $aIncludes index. 311 $a1-119-14107-9 327 $aAnalytics for Insurance: The Real Business of Big Data; Contents; Preface; Acknowledgements; About the Author; Chapter 1: Introduction - The New 'Real Business'; 1.1 On the Point of Transformation; 1.1.1 Big Data Defined by Its Characteristics; 1.1.2 The Hierarchy of Analytics, and How Value is Obtained from Data; 1.1.3 Next Generation Analytics; 1.1.4 Between the Data and the Analytics; 1.2 Big Data and Analytics for all Insurers; 1.2.1 Three Key Imperatives; 1.2.2 The Role of Intermediaries; 1.2.3 Geographical Perspectives; 1.2.4 Analytics and the Internet of Things 327 $a1.2.5 Scale Benefit - or Size Disadvantage?1.3 How do Analytics Actually Work?; 1.3.1 Business Intelligence; 1.3.2 Predictive Analytics; 1.3.3 Prescriptive Analytics; 1.3.4 Cognitive Computing; Notes; Chapter 2: Analytics and the Office of Finance; 2.1 The Challenges of Finance; 2.2 Performance Management and Integrated Decision-Making; 2.3 Finance and Insurance; 2.4 Reporting and Regulatory Disclosure; 2.5 GAAP and IFRS; 2.6 Mergers, Acquisitions and Divestments; 2.7 Transparency, Misrepresentation, the Securities Act and 'SOX'; 2.8 Social Media and Financial Analytics 327 $a2.9 Sales Management and Distribution Channels2.9.1 Agents and Producers; 2.9.2 Distribution Management; Notes; Chapter 3: Managing Financial Risk Across the Insur ance Enterprise; 3.1 Solvency II; 3.2 Solvency II, Cloud Computing and Shared Services; 3.3 'Sweating the Assets'; 3.4 Solvency II and IFRS; 3.5 The Changing Role of the CRO; 3.6 CRO as Customer Advocate; 3.7 Analytics and the Challenge of Unpredictability; 3.8 The Importance of Reinsurance; 3.9 Risk Adjusted Decision-Making; Notes; Chapter 4: Underwriting; 4.1 Underwriting and Big Data; 4.2 Underwriting for Specialist Lines 327 $a4.3 Telematics and User-Based Insurance as an Underwriting Tool4.4 Underwriting for Fraud Avoidance; 4.5 Analytics and Building Information Management (BIM); Notes; Chapter 5: Claims and the 'Moment of Truth'; 5.1 'Indemnity' and the Contractual Entitlement; 5.2 Claims Fraud; 5.2.1 Opportunistic Fraud; 5.2.1.1 Analytics in Opportunistic Fraud; 5.2.2 Organized Fraud; 5.2.2.1 Organized Fraud Detection through Network Analytics; 5.2.2.2 Voice Analytics in the Claims Fraud Process; 5.2.2.3 Fraud Analytics at Inception; 5.3 Property Repairs and Supply Chain Management; 5.4 Auto Repairs 327 $a5.5 Transforming the Handling of Complex Domestic Claims5.5.1 The Digital Investigator; 5.5.2 Potential Changes in the Claims Process; 5.5.3 Reinvention of the Supplier Ecosystem; 5.6 Levels of Inspection; 5.6.1 Reserving; 5.6.2 Business Interruption; 5.6.3 Subrogation; 5.7 Motor Assessing and Loss Adjusting; 5.7.1 Motor Assessing; 5.7.2 Loss Adjusting; 5.7.3 Property Claims Networks; 5.7.4 Adjustment of Cybersecurity Claims; 5.7.5 The Demographic Time Bomb in Adjusting; Notes; Chapter 6: Analytics and Marketing; 6.1 Customer Acquisition and Retention; 6.2 Social Media Analytics 327 $a6.3 Demography and How Population Matters 330 $a"The business guide to Big Data in insurance, with practical application insight Big Data and Analytics for Insurers is the industry-specific guide to creating operational effectiveness, managing risk, improving financials, and retaining customers. Written from a non-IT perspective, this book focusses less on the architecture and technical details, instead providing practical guidance on translating analytics into target delivery. The discussion examines implementation, interpretation, and application to show you what Big Data can do for your business, with insights and examples targeted specifically to the insurance industry. From fraud analytics in claims management, to customer analytics, to risk analytics in Solvency 2, comprehensive coverage presented in accessible language makes this guide an invaluable resource for any insurance professional. The insurance industry is heavily dependent on data, and the advent of Big Data and analytics represents a major advance with tremendous potential - yet clear, practical advice on the business side of analytics is lacking. This book fills the void with concrete information on using Big Data in the context of day-to-day insurance operations and strategy. Understand what Big Data is and what it can do Delve into Big Data's specific impact on the insurance industry Learn how advanced analytics can revolutionise the industry Bring Big Data out of IT and into strategy, management, marketing, and more Big Data and analytics is changing business - but how? The majority of Big Data guides discuss data collection, database administration, advanced analytics, and the power of Big Data - but what do you actually do with it? Big Data and Analytics for Insurers answers your questions in real, everyday business terms, tailored specifically to the insurance industry's unique needs, challenges, and targets"--$cProvided by publisher. 330 $a"The book will deal with Big Data and Analytics specifically from an insurance perspective"--$cProvided by publisher. 410 0$aWiley finance series. 606 $aInsurance$xComputer network resources 606 $aAssegurances$2thub 606 $aRecursos electrònics en xarxa$2thub 608 $aLlibres electrònics$2thub 615 0$aInsurance$xComputer network resources. 615 7$aAssegurances 615 7$aRecursos electrònics en xarxa 676 $a368.00285 686 $aBUS004000$2bisacsh 700 $aBoobier$b Tony$01612399 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910809425103321 996 $aAnalytics for insurance$93941164 997 $aUNINA LEADER 06478nam 2200697 a 450 001 9910808298603321 005 20240516181441.0 010 $a9786613675132 010 $a9781118345344 010 $a1118345347 010 $a9781280698170 010 $a1280698179 010 $a9781118345320 010 $a1118345320 010 $a9781118345313 010 $a1118345312 010 $a9781118345337 010 $a1118345339 035 $a(CKB)2670000000206352 035 $a(EBL)938872 035 $a(OCoLC)795120561 035 $a(SSID)ssj0000679498 035 $a(PQKBManifestationID)11400051 035 $a(PQKBTitleCode)TC0000679498 035 $a(PQKBWorkID)10610025 035 $a(PQKB)10207249 035 $a(MiAaPQ)EBC938872 035 $a(Au-PeEL)EBL938872 035 $a(CaPaEBR)ebr10580247 035 $a(CaONFJC)MIL367513 035 $a(Perlego)1013268 035 $a(EXLCZ)992670000000206352 100 $a20120119d2012 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aVaccinology $eprinciples and practice /$fedited by W. John W. Morrow ... [et al.] 205 $a1st ed. 210 $aChichester [England] $cWiley-Blackwell$d2012 215 $a1 online resource (554 p.) 300 $aDescription based upon print version of record. 311 08$a9781405185745 311 08$a1405185740 320 $aIncludes bibliographical references and index. 327 $aMachine generated contents note: List of ContributorsPrefacePart 1: Introduction1 Concept & Scope of Modern VaccinesNadeem Sheikh PhD, Huw Davies PhD, Clint Schmidt PhDPart 2: Principles of Vaccine Design2 Strategies to Stimulate Innate Immunity for Designing Effective Vaccine AdjuvantsHeather L. Wilson PhD, Scott Napper PhD, George K. Mutwiri, Sylvia van Drunen-Little van den Hurk, Hugh Townsend PhD VIDO, Lorne A. Babiuk PhD, Andrew A. Potter PhD, Volker Gerdts PhD3 Antigen Processing and Presentation by MHC Class I, II and Non-Classical MoleculesAnthony N. Antoniou PhD, Izabela Lenart, David B. Guiliano, Simon J. Powis PhD4 Understanding the Mucosal Immune System for Better Mucosal VaccineJanine Bilsborough PhD, Joanne L. Viney PhD5 Immunological Memory: T Cells in HumansMaria Candela Iglesias, Victor Appay PhD, Arnaud Moris,6 Immunological Memory: B CellsFrances Eun-Hyung Lee MD, In?aki Sanz MD7 Utility of Mouse Models in Vaccine Design and DevelopmentCatherine M. Bosio PhD, Megan McLeod PhD, Philippa Marrack PhD, Ross M. Kedl8 Utility of Non-Human Primate Models for VaccinePreston A. Marx PhD, Alexander F. VoevodinPart 3: Antigen Discovery (Macro approach vs. Epitope focused)9 Sequence Based Computational Approaches to Vaccine Discovery and DesignDarrick Carter PhD10 High-Throughput Proteomics (Microarrays only)Huw Davies PhD11 Phage LibrariesAaron K. Sato PhDPart 4: Antigen Engineering12 Attenuated Microbial VaccinesRichard W. Titball BSc, FRCPath, Helen S. Atkins BSc, PhD13 Virus-Like Particles as Antigen ScaffoldsBryce Chackerian PhD, John T. Schiller PhD14 Recombinant MVA Vaccines, Optimisation, Pre-clinical and Product DevelopmentYper Hall BSc, Miles Carroll PhD15 Recombinant Adenoviruses for VaccinationNelson Cesar Di Paolo PhD, Dmitry Shayakhmetov PhD, Andre; Lieber MD, PhD16 Recombinant AvipoxvirusesMichael A. Skinner PhD, Stephen M. Laidlaw17 Intracellular Facultative Bacterial Vectors For Cancer ImmunotherapyPatrick Guirnalda , Laurence Wood, Matthew Seavy, Yvonne Paterson PhD18 Nucleic Acid VaccinationBritta Wahren, Margaret A. Liu MD19 Artificial Antigen-presenting Cells: Large Multivalent ImmunogensMatthew F. Mescher PhD, Julie M. CurtsingerPart 5: Delivery Systems20 Transcutaneous Immunization via Vaccine Patch Delivery SystemRobert C. Seid PhD, Gregory M. Glenn MD21 Needle-free Jet Injection for Vaccine AdministrationBrian R. Sloat, Hoi K. Tran, Zhengrong Cui PhD22 Oral Vaccines: an old need and some new possibilitiesAmit A. Lugade PhD, Kalathil Suresh PhD, Yasmin Thanavala PhD23 Adjuvants: From Serendipity to Rational DiscoveryDerek T. O'Hagan PhD, Andreas Wack PhD24 Immunostimulatory Properties of Biodegradable MicroparticlesF.A. Sharp, E.C. Lavelle25 Co-administration of Costimulatory MoietiesCarolina Arancibia, Yvette Latchman PhD26 Toll Receptors in Relation to Adjuvant EffectsDipshikha Chakravortty PhD, Amit Lahiri PhD, Priyanka Das PhDPart 6: Regulatory Considerations27 Regulatory Issues (FDA & EMEA)Murrium Ahmad PhD, Victoria Byers, Peter WilsonPart 7: Evaluating Vaccine Efficacy28 Immune Monitoring Design within the Development Pipeline for an Immunotherapeutic or Preventive VaccineSylvia Janetzki PhD, Pedro Romero MD, Mario Roederer PhD, Diane L. Bolton PhD, Camilla Jandus29 Clinical Development Strategy: Nuts and BoltsCandida Fratazzi MD, Claudio Carini MD, PhD30 Current Approaches to Identify and Evaluate Cancer Biomarkers for Patient StratificationRobert C Rees PhD, Stephanie Laversin, Cliff Murray PhD, Graham Ball PhDPart 8: Implementing Immunizations/Therapies31 Mass Immunization StrategiesDavid L. Heymann MD, DTM&H, Bruce R. Aylward, Rudolf H. Tangermann32 The Role of Mathematical Models in Vaccine Development and Public Health Decision MakingMarie-Claude Boily PhD, Marc Brisson PhD, Benoit Ma?sse PhD, Sir Roy M Anderson FRS, FMedSci33 Vaccine SafetyJohn Iskander MD, MPH, Claudia Vellozzi MD, MPH, Jane Gidudu MD, MPH, Robert T. Chen MD, MA. 330 $a"This book addresses a profound deficiency in the field of vaccine research and development, namely the lack of a single volume describing the design and construction of vaccine strategies from first principles to implementation. This is an authoritative textbook that details a comprehensive and systematic approach to the science of vaccinology focusing on not only basic science, but the many stages required to commercialize and navigate the regulatory requirements for human application both in the United States and Europe. The book has broad appeal to clinicians, scientific and medical researchers alike, and graduate students"--Provided by publisher. 606 $aVaccines 606 $aVaccination 615 0$aVaccines. 615 0$aVaccination. 676 $a615.3/72 701 $aMorrow$b John$f1949-$01608510 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910808298603321 996 $aVaccinology$94114324 997 $aUNINA